Soc. Generale Call 1200 DSV Panal.../ DE000SW7P782 /
30/05/2024 21:40:13 | Diferencia-0.001 | Bid8:00:00 | Ask8:00:00 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.001EUR | -50.00% | 0.001 Volumen de oferta: 10,000 |
0.040 Tamaño/ Volumen/ Formato de Ask: 10,000 |
- | 1,200.00 DKK | 21/06/2024 | Call |
GlobeNewswire
8:00
Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
GlobeNewswire
7:30
Baosheng Media Group Holdings Limited Announces Filing of Current Report on Form 6-K with the SEC re...
GlobeNewswire
7:05
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
GlobeNewswire
7:05
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
GlobeNewswire
7:00
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type ...
GlobeNewswire
7:00
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with typ...
GlobeNewswire
7:00
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
GlobeNewswire
6:08
Sen. John Cornyn delivers remarks at Driscoll Children's Hospital Rio Grande Valley
GlobeNewswire
5:00
Flash News: OKX to List Ultiverse's Token on its Spot Market, Expanding Trading Options
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página